Latest papers

No-reflow phenomenon in cardiac MRI: diagnosis and clinical implications.

Impact of metabolic syndrome on no-reflow after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction.

[Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].

Pharmacological approach of no-reflow phenomenon related with percutaneous coronary interventions.

[Cardiac magnetic resonance imaging in the diagnosis of acute coronary syndrome. Basics and clinical value]

Failed percutaneous coronary intervention: a decade of experience in 21,000 patients.

Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time?

Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.

Nicardipine and adenosine "flush cocktail" to prevent no-reflow during rotational atherectomy.

Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.

A rare case of thromboembolism in a 21-year old female with elevated factor VIII.

Intravenous nicorandil preserves endothelial junctions by decreasing endothelin-1 via activation of ATP-sensitive K+ channel.

Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction?

[The no reflow phenomenon in acute myocardial infarction: cause or consequence of myocardial cells injury].

The effect of statins on the no-reflow phenomenon: an observational study in patients with hyperglycemia before primary angioplasty.